{
  "MedlineCitation": {
    "CitationSubset": [
      "IM"
    ],
    "KeywordList": [
      [
        "H. pylori",
        "ICI",
        "diet",
        "gastric cancer",
        "gut microbiota",
        "immunotherapy",
        "immunotherapy response",
        "malnutrition",
        "muscle mass",
        "nutrition",
        "nutritional status"
      ]
    ],
    "GeneralNote": [],
    "SpaceFlightMission": [],
    "InvestigatorList": [],
    "OtherAbstract": [],
    "OtherID": [],
    "PMID": "38787209",
    "DateCompleted": {
      "Year": "2025",
      "Month": "03",
      "Day": "03"
    },
    "DateRevised": {
      "Year": "2025",
      "Month": "04",
      "Day": "25"
    },
    "Article": {
      "ArticleDate": [
        {
          "Year": "2024",
          "Month": "04",
          "Day": "26"
        }
      ],
      "Language": [
        "eng"
      ],
      "ELocationID": [
        "357",
        "10.3390/pathogens13050357"
      ],
      "Journal": {
        "ISSN": "2076-0817",
        "JournalIssue": {
          "Volume": "13",
          "Issue": "5",
          "PubDate": {
            "Year": "2024",
            "Month": "Apr",
            "Day": "26"
          }
        },
        "Title": "Pathogens (Basel, Switzerland)",
        "ISOAbbreviation": "Pathogens"
      },
      "ArticleTitle": "Gastric Cancer, Immunotherapy, and Nutrition: The Role of Microbiota.",
      "Abstract": {
        "AbstractText": [
          "Immune checkpoint inhibitors (ICI) have revolutionized the treatment of gastric cancer (GC), which still represents the third leading cause of cancer-related death in Western countries. However, ICI treatment outcomes vary between individuals and need to be optimized. Recent studies have shown that gut microbiota could represent a key influencer of immunotherapy responses. At the same time, the nutritional status and diet of GC patients are also predictive of immunotherapy treatment response and survival outcomes. The objective of this narrative review is to gather recent findings about the complex relationships between the oral, gastric, and gut bacterial communities, dietary factors/nutritional parameters, and immunotherapy responses. Perigastric/gut microbiota compositions/functions and their metabolites could be predictive of response to immunotherapy in GC patients and even overall survival. At the same time, the strong influence of diet on the composition of the microbiota could have consequences on immunotherapy responses through the impact of muscle mass in GC patients during immunotherapy. Future studies are needed to define more precisely the dietary factors, such as adequate daily intake of prebiotics, that could counteract the dysbiosis of the GC microbiota and the impaired nutritional status, improving the clinical outcomes of GC patients during immunotherapy."
        ]
      },
      "AuthorList": [
        {
          "AffiliationInfo": [
            {
              "Identifier": [],
              "Affiliation": "Clinical Nutrition Unit, Department of Medical and Abdominal Surgery and Endocrine-Metabolic Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy."
            }
          ],
          "Identifier": [
            "0000-0001-6569-1082"
          ],
          "LastName": "Raoul",
          "ForeName": "Pauline",
          "Initials": "P"
        },
        {
          "AffiliationInfo": [
            {
              "Identifier": [],
              "Affiliation": "School of Specialization in Internal Medicine, Catholic University of the Sacred Heart, 00168 Rome, Italy."
            }
          ],
          "Identifier": [],
          "LastName": "De Gaetano",
          "ForeName": "Valeria",
          "Initials": "V"
        },
        {
          "AffiliationInfo": [
            {
              "Identifier": [],
              "Affiliation": "School of Specialization in Internal Medicine, Catholic University of the Sacred Heart, 00168 Rome, Italy."
            }
          ],
          "Identifier": [],
          "LastName": "Sciaraffia",
          "ForeName": "Gianmario",
          "Initials": "G"
        },
        {
          "AffiliationInfo": [
            {
              "Identifier": [],
              "Affiliation": "Degree Course in Pharmacy, Catholic University of the Sacred Heart, 00168 Rome, Italy."
            }
          ],
          "Identifier": [],
          "LastName": "Ormea",
          "ForeName": "Ginevra",
          "Initials": "G"
        },
        {
          "AffiliationInfo": [
            {
              "Identifier": [],
              "Affiliation": "Clinical Nutrition Unit, Department of Medical and Abdominal Surgery and Endocrine-Metabolic Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy."
            },
            {
              "Identifier": [],
              "Affiliation": "Research and Training Center in Human Nutrition, Catholic University of the Sacred Heart, 00168 Rome, Italy."
            }
          ],
          "Identifier": [
            "0000-0002-9610-0748"
          ],
          "LastName": "Cintoni",
          "ForeName": "Marco",
          "Initials": "M"
        },
        {
          "AffiliationInfo": [
            {
              "Identifier": [],
              "Affiliation": "Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy."
            }
          ],
          "Identifier": [
            "0000-0003-4004-9098"
          ],
          "LastName": "Pozzo",
          "ForeName": "Carmelo",
          "Initials": "C"
        },
        {
          "AffiliationInfo": [
            {
              "Identifier": [],
              "Affiliation": "Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy."
            }
          ],
          "Identifier": [],
          "LastName": "Strippoli",
          "ForeName": "Antonia",
          "Initials": "A"
        },
        {
          "AffiliationInfo": [
            {
              "Identifier": [],
              "Affiliation": "Research and Training Center in Human Nutrition, Catholic University of the Sacred Heart, 00168 Rome, Italy."
            },
            {
              "Identifier": [],
              "Affiliation": "Digestive Disease Center (CEMAD), Department of Medical and Abdominal Surgery and Endocrine-Metabolic Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy."
            },
            {
              "Identifier": [],
              "Affiliation": "Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Rome, Italy."
            }
          ],
          "Identifier": [
            "0000-0002-6230-1779"
          ],
          "LastName": "Gasbarrini",
          "ForeName": "Antonio",
          "Initials": "A"
        },
        {
          "AffiliationInfo": [
            {
              "Identifier": [],
              "Affiliation": "Clinical Nutrition Unit, Department of Medical and Abdominal Surgery and Endocrine-Metabolic Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy."
            },
            {
              "Identifier": [],
              "Affiliation": "Research and Training Center in Human Nutrition, Catholic University of the Sacred Heart, 00168 Rome, Italy."
            },
            {
              "Identifier": [],
              "Affiliation": "Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Rome, Italy."
            }
          ],
          "Identifier": [
            "0000-0002-8463-7062"
          ],
          "LastName": "Mele",
          "ForeName": "Maria Cristina",
          "Initials": "MC"
        },
        {
          "AffiliationInfo": [
            {
              "Identifier": [],
              "Affiliation": "Clinical Nutrition Unit, Department of Medical and Abdominal Surgery and Endocrine-Metabolic Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy."
            },
            {
              "Identifier": [],
              "Affiliation": "Research and Training Center in Human Nutrition, Catholic University of the Sacred Heart, 00168 Rome, Italy."
            },
            {
              "Identifier": [],
              "Affiliation": "Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, 00168 Rome, Italy."
            }
          ],
          "Identifier": [
            "0000-0002-9165-2367"
          ],
          "LastName": "Rinninella",
          "ForeName": "Emanuele",
          "Initials": "E"
        }
      ],
      "PublicationTypeList": [
        "Journal Article",
        "Review"
      ]
    },
    "MedlineJournalInfo": {
      "Country": "Switzerland",
      "MedlineTA": "Pathogens",
      "NlmUniqueID": "101596317",
      "ISSNLinking": "2076-0817"
    },
    "ChemicalList": [
      {
        "RegistryNumber": "0",
        "NameOfSubstance": "Immune Checkpoint Inhibitors"
      }
    ],
    "MeshHeadingList": [
      {
        "QualifierName": [],
        "DescriptorName": "Humans"
      },
      {
        "QualifierName": [],
        "DescriptorName": "Diet"
      },
      {
        "QualifierName": [
          "immunology",
          "therapy"
        ],
        "DescriptorName": "Dysbiosis"
      },
      {
        "QualifierName": [
          "physiology",
          "immunology",
          "drug effects"
        ],
        "DescriptorName": "Gastrointestinal Microbiome"
      },
      {
        "QualifierName": [
          "therapeutic use",
          "pharmacology"
        ],
        "DescriptorName": "Immune Checkpoint Inhibitors"
      },
      {
        "QualifierName": [
          "methods"
        ],
        "DescriptorName": "Immunotherapy"
      },
      {
        "QualifierName": [
          "immunology"
        ],
        "DescriptorName": "Nutritional Status"
      },
      {
        "QualifierName": [
          "immunology",
          "therapy",
          "microbiology"
        ],
        "DescriptorName": "Stomach Neoplasms"
      }
    ],
    "CoiStatement": "The authors declare no conflicts of interest."
  },
  "PubmedData": {
    "ReferenceList": [
      {
        "Reference": [
          {
            "Citation": "Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209\u2013249. doi: 10.3322/caac.21660.",
            "ArticleIdList": [
              "10.3322/caac.21660",
              "33538338"
            ]
          },
          {
            "Citation": "Smyth E.C., Verheij M., Allum W., Cunningham D., Cervantes A., Arnold D. ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27((Suppl. S5)):38\u201349. doi: 10.1093/annonc/mdw350.",
            "ArticleIdList": [
              "10.1093/annonc/mdw350",
              "27664260"
            ]
          },
          {
            "Citation": "Facchinetti F., Di Maio M., Perrone F., Tiseo M. First-line immunotherapy in nonsmall cell lung cancer patients with poor performance status: A systematic review and meta-analysis. Transl. Lung Cancer Res. 2021;10:2917\u20132936. doi: 10.21037/tlcr-21-15.",
            "ArticleIdList": [
              "10.21037/tlcr-21-15",
              "PMC8264315",
              "34295688"
            ]
          },
          {
            "Citation": "Ekmekciu I., von Klitzing E., Fiebiger U., Escher U., Neumann C., Bacher P., Scheffold A., K\u00fchl A.A., Bereswill S., Heimesaat M.M. Immune responses to broad-spectrum antibiotic treatment and fecal microbiota transplantation in mice. Front. Immunol. 2017;8:397. doi: 10.3389/fimmu.2017.00397.",
            "ArticleIdList": [
              "10.3389/fimmu.2017.00397",
              "PMC5395657",
              "28469619"
            ]
          },
          {
            "Citation": "Tanoue T., Morita S., Plichta D.R., Skelly A.N., Suda W., Sugiura Y., Narushima S., Vlamakis H., Motoo I., Sugita K., et al. A definedcommensal consortium elicits CD8 T cells and anti-cancer immunity. Nature. 2019;565:600\u2013605. doi: 10.1038/s41586-019-0878-z.",
            "ArticleIdList": [
              "10.1038/s41586-019-0878-z",
              "30675064"
            ]
          },
          {
            "Citation": "Louis P., Hold G.L., Flint H.J. The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 2014;12:661\u2013672. doi: 10.1038/nrmicro3344.",
            "ArticleIdList": [
              "10.1038/nrmicro3344",
              "25198138"
            ]
          },
          {
            "Citation": "Peng Z., Cheng S., Kou Y., Wang Z., Jin R., Hu H., Zhang X., Gong J.F., Li J., Lu M., et al. The gut microbiome is associated with clinical response to anti-PD-1/PD-L1 immunotherapy in gastrointestinal cancer. Cancer Immunol. Res. 2020;8:1251\u20131261. doi: 10.1158/2326-6066.CIR-19-1014.",
            "ArticleIdList": [
              "10.1158/2326-6066.CIR-19-1014",
              "32855157"
            ]
          },
          {
            "Citation": "Thrastardottir T.O., Copeland V.J., Constantinou C. The Association Between the Gut Microbiome, Nutritional Habits, Antibiotics, and Gastric Cancer: A Scoping Review. Curr. Nutr. Rep. 2022;11:19\u201338. doi: 10.1007/s13668-021-00391-z.",
            "ArticleIdList": [
              "10.1007/s13668-021-00391-z",
              "35020173"
            ]
          },
          {
            "Citation": "Sheh A., Fox J.G. The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis. Gut Microbes. 2013;4:505\u2013531. doi: 10.4161/gmic.26205.",
            "ArticleIdList": [
              "10.4161/gmic.26205",
              "PMC3928162",
              "23962822"
            ]
          },
          {
            "Citation": "Correa P., Piazuelo B.M. The gastric precancerous cascade. J. Dig. Dis. 2012;13:2\u20139. doi: 10.1111/j.1751-2980.2011.00550.x.",
            "ArticleIdList": [
              "10.1111/j.1751-2980.2011.00550.x",
              "PMC3404600",
              "22188910"
            ]
          },
          {
            "Citation": "Ferreira R.M., Pereira-Marques J., Pinto-Ribeiro I., Costa J.L., Carneiro F., Machado J.C., Figueiredo C. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut. 2018;67:226\u2013236. doi: 10.1136/gutjnl-2017-314205.",
            "ArticleIdList": [
              "10.1136/gutjnl-2017-314205",
              "PMC5868293",
              "29102920"
            ]
          },
          {
            "Citation": "Brandt S., Kwok T., Hartig R., K\u00f6nig W., Backert S. NF-kappaB activation and potentiation of proinflammatory responses by the Helicobacter pylori CagA protein. Proc. Natl. Acad. Sci. USA. 2005;102:9300\u20139305. doi: 10.1073/pnas.0409873102.",
            "ArticleIdList": [
              "10.1073/pnas.0409873102",
              "PMC1166591",
              "15972330"
            ]
          },
          {
            "Citation": "Wei J., Noto J.M., Zaika E., Romero-Gallo J., Piazuelo M.B., Schneider B., El-Rifai W., Correa P., Peek R.M., Zaika A.I. Bacterial CagA protein induces degradation of p53 protein in a p14ARF-dependent manner. Gut. 2015;64:1040\u20131048. doi: 10.1136/gutjnl-2014-307295.",
            "ArticleIdList": [
              "10.1136/gutjnl-2014-307295",
              "PMC4312278",
              "25080447"
            ]
          },
          {
            "Citation": "Caron T.J., Scott K.S., Fox J.G., Hagen S.J. Tight junction disruption: Helicobacter pylori and dysregulation of the gastric mucosal barrier. World J. Gastroenterol. 2015;21:11411\u201311427. doi: 10.3748/wjg.v21.i40.11411.",
            "ArticleIdList": [
              "10.3748/wjg.v21.i40.11411",
              "PMC4616217",
              "26523106"
            ]
          },
          {
            "Citation": "Bess\u00e8de E., Staedel C., Acu\u00f1a Amador L.A., Nguyen P.H., Chambonnier L., Hatakeyama M., Belleann\u00e9e G., M\u00e9graud F., Varon C. Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transition-like changes. Oncogene. 2014;33:4123\u20134131. doi: 10.1038/onc.2013.380.",
            "ArticleIdList": [
              "10.1038/onc.2013.380",
              "24096479"
            ]
          },
          {
            "Citation": "Holokai L., Chakrabarti J., Broda T., Chang J., Hawkins J.A., Sundaram N., Wroblewski L.E., Peek R.M., Jr., Wang J., Helmrath M., et al. Increased Programmed Death-Ligand 1 is an Early Epithelial Cell Response to Helicobacter pylori Infection. PLoS Pathog. 2019;15:e1007468. doi: 10.1371/journal.ppat.1007468.",
            "ArticleIdList": [
              "10.1371/journal.ppat.1007468",
              "PMC6380601",
              "30703170"
            ]
          },
          {
            "Citation": "Yang L., Zhang J., Xu J., Wei X., Yang J., Liu Y., Li H., Zhao C., Wang Y., Zhang L., et al. Helicobacter pylori Infection Aggravates Dysbiosis of Gut Microbiome in Children with Gastritis. Front. Cell. Infect. Microbiol. 2019;375:7\u20139. doi: 10.3389/fcimb.2019.00375.",
            "ArticleIdList": [
              "10.3389/fcimb.2019.00375",
              "PMC6859803",
              "31781514"
            ]
          },
          {
            "Citation": "Miftahussurur M., Waskito L.A., El-Serag H.B., Ajami N.J., Nusi I.A., Syam A.F., Matsumoto T., Rezkitha Y.A.A., Doohan D., Fauzia K.A., et al. Gastric microbiota and Helicobacter pylori in Indonesian population. Helicobacter. 2020;25:e12695. doi: 10.1111/hel.12695.",
            "ArticleIdList": [
              "10.1111/hel.12695",
              "32395907"
            ]
          },
          {
            "Citation": "Nasr R., Shamseddine A., Mukherji D., Nassar F., Temraz S. The Crosstalk between Microbiome and Immune Response in Gastric Cancer. Int. J. Mol. Sci. 2020;21:6586. doi: 10.3390/ijms21186586.",
            "ArticleIdList": [
              "10.3390/ijms21186586",
              "PMC7556019",
              "32916853"
            ]
          },
          {
            "Citation": "Zhang S., Shi D., Li M., Li Y., Wan X., Li W. The relationship between gastric microbiota and gastric disease. Scand. J. Gastroenterol. 2019;54:391\u2013396. doi: 10.1080/00365521.2019.1591499.",
            "ArticleIdList": [
              "10.1080/00365521.2019.1591499",
              "30945954"
            ]
          },
          {
            "Citation": "Hu Y.L., Pang W., Huang Y., Zhang Y., Zhang C.J. The Gastric Microbiome Is Perturbed in Advanced Gastric Adenocarcinoma Identified Through Shotgun Metagenomics. Front. Cell. Infect. Microbiol. 2018;12:8\u2013433. doi: 10.3389/fcimb.2018.00433.",
            "ArticleIdList": [
              "10.3389/fcimb.2018.00433",
              "PMC6299874",
              "30619779"
            ]
          },
          {
            "Citation": "Sohn S.H., Kim N., Jo H.J., Kim J., Park J.H., Nam R.H., Seok Y.J., Kim Y.R., Lee D.H. Erratum: Analysis of Gastric Body Microbiota by Pyrosequencing: Possible Role of Bacteria Other Than Helicobacter pylori in the Gastric Carcinogenesis. J. Cancer Prev. 2017;22:267. doi: 10.15430/JCP.2017.22.4.267.",
            "ArticleIdList": [
              "10.15430/JCP.2017.22.4.267",
              "PMC5751846",
              "29302586"
            ]
          },
          {
            "Citation": "Gantuya B., El Serag H.B., Matsumoto T., Ajami N.J., Uchida T., Oyuntsetseg K., Bolor D., Yamaoka Y. Gastric mucosal microbiota in a Mongolian population with gastric cancer and precursor conditions. Aliment. Pharmacol. Ther. 2020;51:770\u2013780. doi: 10.1111/apt.15675.",
            "ArticleIdList": [
              "10.1111/apt.15675",
              "PMC8761497",
              "32133670"
            ]
          },
          {
            "Citation": "Nougayr\u00e8de J.P., Homburg S., Taieb F., Boury M., Brzuszkiewicz E., Gottschalk G., Buchrieser C., Hacker J., Dobrindt U., Oswald E. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science. 2006;313:848\u2013851. doi: 10.1126/science.1127059.",
            "ArticleIdList": [
              "10.1126/science.1127059",
              "16902142"
            ]
          },
          {
            "Citation": "Soda K. The mechanisms by which polyamines accelerate tumor spread. J. Exp. Clin. Cancer Res. 2011;30:95. doi: 10.1186/1756-9966-30-95.",
            "ArticleIdList": [
              "10.1186/1756-9966-30-95",
              "PMC3206444",
              "21988863"
            ]
          },
          {
            "Citation": "Fisher L., Fisher A. Acid-Suppressive Therapy and Risk of Infections: Pros and Cons. Clin. Drug Investig. 2017;37:587\u2013624. doi: 10.1007/s40261-017-0519-y.",
            "ArticleIdList": [
              "10.1007/s40261-017-0519-y",
              "28361440"
            ]
          },
          {
            "Citation": "Hun R.H., Camilleri M., Crowe S.E., El-Omar E.M., Fox J.G., Kuipers E.J., Malfertheiner P., McColl K.E.L., Pritchard D.M., Rugge M., et al. The stomach in health and disease. Gut. 2015;64:1650\u20131668. doi: 10.1136/gutjnl-2014-307595.",
            "ArticleIdList": [
              "10.1136/gutjnl-2014-307595",
              "PMC4835810",
              "26342014"
            ]
          },
          {
            "Citation": "L\u00f3pez-Brea M., Alarc\u00f3n T., Domingo D., D\u00edaz-Rega\u00f1\u00f3n J. Inhibitory effect of Gram-negative and Gram-positive microorganisms against Helicobacter pylori clinical isolates. J. Antimicrob. Chemother. 2008;61:139\u2013142. doi: 10.1093/jac/dkm404.",
            "ArticleIdList": [
              "10.1093/jac/dkm404",
              "17965421"
            ]
          },
          {
            "Citation": "Shen Z., Dzink-Fox J., Feng Y., Muthupalani S., Mannion A.J., Sheh A., Whary M.T., Holcombe H.R., Piazuelo B.M., Bravo L.E., et al. Gastric Non-Helicobacter pylori Urease-Positive Staphylococcus epidermidis and Streptococcus salivarius Isolated from Humans Have Contrasting Effects on H. pylori-Associated Gastric Pathology and Host Immune Responses in a Murine Model of Gastric Cancer. mSphere. 2022;7:e0077221. doi: 10.1128/msphere.00772-21.",
            "ArticleIdList": [
              "10.1128/msphere.00772-21",
              "PMC8826947",
              "35138124"
            ]
          },
          {
            "Citation": "Yang I., Woltemate S., Piazuelo M.B., Bravo L.E., Yepez M.C., Romero-Gallo J., Delgado A.G., Wilson K.T., Peek R.M., Correa P., et al. Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia. Sci Rep. 2016;6:18594. doi: 10.1038/srep18594.",
            "ArticleIdList": [
              "10.1038/srep18594",
              "PMC4700446",
              "26729566"
            ]
          },
          {
            "Citation": "Casta\u00f1o-Rodr\u00edguez N., Goh K.L., Fock K.M., Mitchell H.M., Kaakoush N.O. Dysbiosis of the microbiome in gastric carcinogenesis. Sci. Rep. 2017;7:15957. doi: 10.1038/s41598-017-16289-2.",
            "ArticleIdList": [
              "10.1038/s41598-017-16289-2",
              "PMC5698432",
              "29162924"
            ]
          },
          {
            "Citation": "San-Mill\u00e1n I., Brooks G.A. Reexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect. Carcinogenesis. 2017;38:119\u2013133. doi: 10.1093/carcin/bgw127.",
            "ArticleIdList": [
              "10.1093/carcin/bgw127",
              "PMC5862360",
              "27993896"
            ]
          },
          {
            "Citation": "Lertpiriyapong K., Whary M.T., Muthupalani S., Lofgren J.L., Gamazon E.R., Feng Y., Ge Z., Wang T.C., Fox J.G. Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis. Gut. 2014;63:54\u201363. doi: 10.1136/gutjnl-2013-305178.",
            "ArticleIdList": [
              "10.1136/gutjnl-2013-305178",
              "PMC4023484",
              "23812323"
            ]
          },
          {
            "Citation": "Hsieh Y.Y., Tung S.Y., Pan H.Y., Chang T.S., Wei K.L., Chen W.M., Deng Y.-F., Lu C.-K., Lai Y.-H., Wu C.-S., et al. Fusobacterium nucleatum colonization is associated with decreased survival of Helicobacter pylori-positive gastric cancer patients. World J. Gastroenterol. 2021;27:7311\u20137323. doi: 10.3748/wjg.v27.i42.7311.",
            "ArticleIdList": [
              "10.3748/wjg.v27.i42.7311",
              "PMC8611209",
              "34876791"
            ]
          },
          {
            "Citation": "Rubinstein M.R., Wang X., Liu W., Hao Y., Cai G., Han Y.W. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/\u03b2-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013;14:195\u2013206. doi: 10.1016/j.chom.2013.07.012.",
            "ArticleIdList": [
              "10.1016/j.chom.2013.07.012",
              "PMC3770529",
              "23954158"
            ]
          },
          {
            "Citation": "Brennan C.A., Garrett W.S. Gut microbiota, inflammation, and colorectal cancer. Annu. Rev. Microbiol. 2016;70:395\u2013411. doi: 10.1146/annurev-micro-102215-095513.",
            "ArticleIdList": [
              "10.1146/annurev-micro-102215-095513",
              "PMC5541233",
              "27607555"
            ]
          },
          {
            "Citation": "Kostic A.D., Chun E., Robertson L., Glickman J.N., Gallini C.A., Michaud M., Clancy T.E., Chung D.C., Lochhead P., Hold G.L., et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14:207\u2013215. doi: 10.1016/j.chom.2013.07.007.",
            "ArticleIdList": [
              "10.1016/j.chom.2013.07.007",
              "PMC3772512",
              "23954159"
            ]
          },
          {
            "Citation": "Kwon S.K., Park J.C., Kim K.H., Yoon J., Cho Y., Lee B., Lee J.-J., Jeong H., Oh Y., Kim S.-H., et al. Human gastric microbiota transplantation recapitulates premalignant lesions in germ-free mice. Gut. 2022;71:1266\u20131276. doi: 10.1136/gutjnl-2021-324489.",
            "ArticleIdList": [
              "10.1136/gutjnl-2021-324489",
              "34389621"
            ]
          },
          {
            "Citation": "Erawijantari P.P., Mizutani S., Shiroma H., Shiba S., Nakajima T., Sakamoto T., Saito Y., Fukuda S., Yachida S., Yamada T. Influence of gastrectomy for gastric cancer treatment on faecal microbiome and metabolome profiles. Gut. 2020;69:1404\u20131415. doi: 10.1136/gutjnl-2019-319188.",
            "ArticleIdList": [
              "10.1136/gutjnl-2019-319188",
              "PMC7398469",
              "31953253"
            ]
          },
          {
            "Citation": "Liu S., Dai J., Lan X., Fan B., Dong T., Zhang Y., Han M. Intestinal bacteria are potential biomarkers and therapeutic targets for gastric cancer. Microb. Pathog. 2021;151:104747. doi: 10.1016/j.micpath.2021.104747.",
            "ArticleIdList": [
              "10.1016/j.micpath.2021.104747",
              "33484807"
            ]
          },
          {
            "Citation": "Chen X.H., Wang A., Chu A.N., Gong Y.H., Yuan Y. Mucosa-associated microbiota in gastric cancer tissues compared with non-cancer tissues. Front. Microbiol. 2019;10:1261. doi: 10.3389/fmicb.2019.01261.",
            "ArticleIdList": [
              "10.3389/fmicb.2019.01261",
              "PMC6560205",
              "31231345"
            ]
          },
          {
            "Citation": "Man S.M. Inflammasomes in the gastrointestinal tract: Infection, cancer and gut microbiota homeostasis. Nat. Rev. Gastroenterol. Hepatol. 2018;15:721\u2013737. doi: 10.1038/s41575-018-0054-1.",
            "ArticleIdList": [
              "10.1038/s41575-018-0054-1",
              "PMC7097092",
              "30185915"
            ]
          },
          {
            "Citation": "Cavadas B., Camacho R., Ferreira J.C., Ferreira R.M., Figueiredo C., Brazma A., Fonseca N.A., Pereira L. Gastric microbiome diversities in gastric cancer patients from Europe and Asia mimic the human population structure and are partly driven by microbiome quantitative trait loci. Microorganisms. 2020;8:1196. doi: 10.3390/microorganisms8081196.",
            "ArticleIdList": [
              "10.3390/microorganisms8081196",
              "PMC7463948",
              "32781641"
            ]
          },
          {
            "Citation": "Chen C., Shen J., Du Y., Shi X., Niu Y., Jin G., Liu Y., Shi Y., Lyu J., Lin L. Characteristics of gut microbiota in patients with gastric cancer by surgery, chemotherapy, and lymph node metastasis. Clin. Transl. Oncol. 2022;24:2181\u20132190. doi: 10.1007/s12094-022-02875-y.",
            "ArticleIdList": [
              "10.1007/s12094-022-02875-y",
              "35794453"
            ]
          },
          {
            "Citation": "Maldonado-Contreras A., Goldfarb K.C., Godoy-Vitorino F., Karaoz U., Contreras M., Blaser M.J., Brodie E.L., Dominguez-Bello M.G. Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J. 2011;5:574\u2013579. doi: 10.1038/ismej.2010.149.",
            "ArticleIdList": [
              "10.1038/ismej.2010.149",
              "PMC3105737",
              "20927139"
            ]
          },
          {
            "Citation": "Heimesaat M.M., Fischer A., Plickert R., Wiedemann T., Loddenkemper C., G\u00f6bel U.B., Bereswill S., Rieder G. Helicobacter pylori-induced gastric immunopathology is associated with distinct microbiota changes in the large intestines of long-term infected Mongolian gerbils. PLoS ONE. 2014;9:e100362. doi: 10.1371/journal.pone.0100362.",
            "ArticleIdList": [
              "10.1371/journal.pone.0100362",
              "PMC4062524",
              "24941045"
            ]
          },
          {
            "Citation": "Bakhti S.Z., Latifi-Navid S. Interplay and cooperation of Helicobacter pylori and gut microbiota in gastric carcinogenesis. BMC Microbiol. 2021;21:258. doi: 10.1186/s12866-021-02315-x.",
            "ArticleIdList": [
              "10.1186/s12866-021-02315-x",
              "PMC8461988",
              "34556055"
            ]
          },
          {
            "Citation": "Yuan C., Burns M.B., Subramanian S., Blekhman R. Interaction between host MicroRNAs and the gut microbiota in colorectal cancer. mSystems. 2018;3:e00205-17. doi: 10.1128/mSystems.00205-17.",
            "ArticleIdList": [
              "10.1128/mSystems.00205-17",
              "PMC5954203",
              "29795787"
            ]
          },
          {
            "Citation": "Wang Q., Ding H., Dong G., Xu L., Jiang F., Mao Q. Bi-direction effects between microbiome and MiRNAs in carcinogenesis. J. Cancer Res. Clin. Oncol. 2021;147:1299\u20131305. doi: 10.1007/s00432-021-03567-w.",
            "ArticleIdList": [
              "10.1007/s00432-021-03567-w",
              "PMC11801847",
              "33765216"
            ]
          },
          {
            "Citation": "Bi K., Zhang X., Chen W., Diao H. MicroRNAs regulate intestinal immunity and gut microbiota for gastrointestinal health: A comprehensive review. Genes. 2020;11:1075. doi: 10.3390/genes11091075.",
            "ArticleIdList": [
              "10.3390/genes11091075",
              "PMC7564790",
              "32932716"
            ]
          },
          {
            "Citation": "Jin X., Liu Z., Yang D., Yin K., Chang X. Recent Progress and Future Perspectives of Immunotherapy in Advanced Gastric Cancer. Front. Immunol. 2022;13:948647. doi: 10.3389/fimmu.2022.948647.",
            "ArticleIdList": [
              "10.3389/fimmu.2022.948647",
              "PMC9284215",
              "35844558"
            ]
          },
          {
            "Citation": "Chen D.S., Mellman I. Oncology meets Immunology: The cancer immunity cycle. Immunity. 2013;39:1\u201310. doi: 10.1016/j.immuni.2013.07.012.",
            "ArticleIdList": [
              "10.1016/j.immuni.2013.07.012",
              "23890059"
            ]
          },
          {
            "Citation": "Ren F., Zhao Q., Zhao M., Zhu S., Liu B., Bukhari I., Zhang K., Wu W., Fu Y., Yu Y., et al. Immune infiltration profiling in gastric cancer and their clinical implications. Cancer Sci. 2021;112:3569\u20133584. doi: 10.1111/cas.15057.",
            "ArticleIdList": [
              "10.1111/cas.15057",
              "PMC8409427",
              "34251747"
            ]
          },
          {
            "Citation": "Uppal A., Dehal A., Chang S.C., Barrak D., Naeini Y., Jalas J.R., Bilchik A.J. The Immune Microenvironment Impacts Survival in Western Patients with Gastric Adenocarcinoma. J. Gastrointest. Surg. 2020;24:28\u201338. doi: 10.1007/s11605-019-04403-w.",
            "ArticleIdList": [
              "10.1007/s11605-019-04403-w",
              "31625020"
            ]
          },
          {
            "Citation": "Sch\u00fcler T., Blankenstein T. Cutting Edge: CD8+ Effector T Cells Reject Tumors by Direct Antigen Recognition but Indirect Action on Host Cells. J. Immunol. 2003;170:4427\u20134431. doi: 10.4049/jimmunol.170.9.4427.",
            "ArticleIdList": [
              "10.4049/jimmunol.170.9.4427",
              "12707316"
            ]
          },
          {
            "Citation": "Ostroumov D., Fekete-Drimusz N., Saborowski M., K\u00fchnel F., Woller N. CD4 and CD8 T lymphocyte interplay in controlling tumor growth. Cell Mol. Life Sci. 2018;75:689\u2013713. doi: 10.1007/s00018-017-2686-7.",
            "ArticleIdList": [
              "10.1007/s00018-017-2686-7",
              "PMC5769828",
              "29032503"
            ]
          },
          {
            "Citation": "Wakatsuki K., Sho M., Yamato I., Takayama T., Matsumoto S., Tanaka T., Migita K., Ito M., Hotta K., Nakajima Y. Clinical impact of tumor-infiltrating CD45RO\u207a memory T cells on human gastric cancer. Oncol. Rep. 2013;29:1756\u20131762. doi: 10.3892/or.2013.2302.",
            "ArticleIdList": [
              "10.3892/or.2013.2302",
              "23440298"
            ]
          },
          {
            "Citation": "Bass A.J., Thorsson V., Shmulevich I., Reynolds S.M., Miller M., Bernard B., Hinoue T., Laird P.W., Curtis C., Shen H., et al. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202\u2013209. doi: 10.1038/nature13480.",
            "ArticleIdList": [
              "10.1038/nature13480",
              "PMC4170219",
              "25079317"
            ]
          },
          {
            "Citation": "Ma C., Patel K., Singhi A.D., Ren B., Zhu B., Shaikh F., Sun W. Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated with Epstein-Barr Virus or Microsatellite Instability. Am. J. Surg. Pathol. 2016;40:1496\u20131506. doi: 10.1097/PAS.0000000000000698.",
            "ArticleIdList": [
              "10.1097/PAS.0000000000000698",
              "27465786"
            ]
          },
          {
            "Citation": "Mastracci L., Grillo F., Parente P., Gullo I., Campora M., Angerilli V., Rossi C., Sacramento M.L., Pennelli G., Vanoli A., et al. PD-L1 evaluation in the gastrointestinal tract: From biological rationale to its clinical application. Pathologica. 2022;114:352\u2013364. doi: 10.32074/1591-951X-803.",
            "ArticleIdList": [
              "10.32074/1591-951X-803",
              "PMC9614301",
              "36305021"
            ]
          },
          {
            "Citation": "Ren J., He Q., Yin H., Zheng L., Li L., Wu X. Prognostic role and clinical significance of tumor-infiltrating lymphocyte (TIL) and programmed death ligand 1 (PD-L1) expression in gastric cancer: A systematic review and meta-analysis. Clin. Transl. Oncol. 2023;25:1436\u20131445. doi: 10.1007/s12094-022-03040-1.",
            "ArticleIdList": [
              "10.1007/s12094-022-03040-1",
              "36528835"
            ]
          },
          {
            "Citation": "Mellman I., Coukos G., Dranoff G. Cancer immunotherapy comes of age. Nature. 2011;480:480\u2013489. doi: 10.1038/nature10673.",
            "ArticleIdList": [
              "10.1038/nature10673",
              "PMC3967235",
              "22193102"
            ]
          },
          {
            "Citation": "Janjigian Y.Y., Shitara K., Moehler M., Garrido M., Salman P., Shen L., Wyrwicz L., Yamaguchi K., Skoczylas T., Campos Bragagnoli A., et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): A randomised, open-label, phase 3 trial. Lancet. 2021;398:27\u201340. doi: 10.1016/S0140-6736(21)00797-2.",
            "ArticleIdList": [
              "10.1016/S0140-6736(21)00797-2",
              "PMC8436782",
              "34102137"
            ]
          },
          {
            "Citation": "Tabernero J., Bang Y.J., Van Cutsem E., Fuchs C.S., Janjigian Y.Y., Bhagia P., Li K., Adelberg D., Qin S.K. KEYNOTE-859, a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma. Future Oncol. 2021;17:2847\u20132855. doi: 10.2217/fon-2021-0176.",
            "ArticleIdList": [
              "10.2217/fon-2021-0176",
              "PMC9892960",
              "33975465"
            ]
          },
          {
            "Citation": "Shitara K., Doi T., Dvorkin M., Mansoor W., Arkenau H.T., Prokharau A., Alsina M., Ghidini M., Faustino C., Gorbunova V., et al. Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): A randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2018;19:1437\u20131448. doi: 10.1016/S1470-2045(18)30739-3.",
            "ArticleIdList": [
              "10.1016/S1470-2045(18)30739-3",
              "30355453"
            ]
          },
          {
            "Citation": "Homann N., Lorenzen S., Schenk M., Thuss-Patience P.C., Goekkurt E., Dieter Hofheinz R., Kretzschmar A., Bolling C., Angermeier S., Wicki A., et al. Interim safety analysis of the DANTE trial: Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma\u2014A randomized, open-label phase II trial of the German Gastric Group at the AIO and SAKK. J. Clin. Oncol. 2020;38:4549. doi: 10.1200/JCO.2020.38.15_suppl.4549.",
            "ArticleIdList": [
              "10.1200/JCO.2020.38.15_suppl.4549"
            ]
          },
          {
            "Citation": "Janjigian Y.Y., Van Cutsem E., Muro K., Wainberg Z., Al-Batran S.E., Hyung W.J., Molena D., Marcovitz M., Ruscica D., Robbins S.H., et al. MATTERHORN: Phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer. Future Oncol. 2022;18:2465\u20132473. doi: 10.2217/fon-2022-0093.",
            "ArticleIdList": [
              "10.2217/fon-2022-0093",
              "35535555"
            ]
          },
          {
            "Citation": "Rizvi N.A., Hellmann M.D., Snyder A., Kvistborg P., Makarov V., Havel J.J., Lee W., Yuan J., Wong P., Ho T.S., et al. Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer. Science. 2015;348:124\u2013128. doi: 10.1126/science.aaa1348.",
            "ArticleIdList": [
              "10.1126/science.aaa1348",
              "PMC4993154",
              "25765070"
            ]
          },
          {
            "Citation": "Riaz N., Havel J.J., Kendall S.M., Makarov V., Walsh L.A., Desrichard A., Weinhold N., Chan T.A. Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy. Nat. Genet. 2016;48:1327\u20131329. doi: 10.1038/ng.3677.",
            "ArticleIdList": [
              "10.1038/ng.3677",
              "PMC5553281",
              "27668655"
            ]
          },
          {
            "Citation": "Carbone D.P., Reck M., Paz-Ares L., Creelan B., Horn L., Steins M., Felip E., van den Heuvel M.M., Ciuleanu T.E., Badin F., et al. CheckMate 026 Investigators. First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer. N. Engl. J. Med. 2017;376:2415\u20132426. doi: 10.1056/NEJMoa1613493.",
            "ArticleIdList": [
              "10.1056/NEJMoa1613493",
              "PMC6487310",
              "28636851"
            ]
          },
          {
            "Citation": "Schumacher T.N., Schreiber R.D. Neoantigens in cancer immunotherapy. Science. 2015;348:69\u201374. doi: 10.1126/science.aaa4971.",
            "ArticleIdList": [
              "10.1126/science.aaa4971",
              "25838375"
            ]
          },
          {
            "Citation": "Spranger S., Bao R., Gajewski T.F. Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity. Nature. 2015;523:231\u2013235. doi: 10.1038/nature14404.",
            "ArticleIdList": [
              "10.1038/nature14404",
              "25970248"
            ]
          },
          {
            "Citation": "Smyth M.J., Ngiow S.F., Ribas A., Teng M.W. Combination cancer immunotherapies tailored to the tumour microenvironment. Nat. Rev. Clin. Oncol. 2016;13:143\u2013158. doi: 10.1038/nrclinonc.2015.209.",
            "ArticleIdList": [
              "10.1038/nrclinonc.2015.209",
              "26598942"
            ]
          },
          {
            "Citation": "Kang Y.K., Boku N., Satoh T., Ryu M.H., Chao Y., Kato K., Chung H.C., Chen J.S., Muro K., Kang W.K., et al. Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390:2461\u20132471. doi: 10.1016/S0140-6736(17)31827-5.",
            "ArticleIdList": [
              "10.1016/S0140-6736(17)31827-5",
              "28993052"
            ]
          },
          {
            "Citation": "Marabelle A., Le D.T., Ascierto P.A., Di Giacomo A.M., De Jesus-Acosta A., Delord J.P., Geva R., Gottfried M., Penel N., Hansen A.R., et al. Efficacy of Pembrolizumab in Patients with Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results from the Phase II KEYNOTE-158 Study. J. Clin. Oncol. 2020;38:1\u201310. doi: 10.1200/JCO.19.02105.",
            "ArticleIdList": [
              "10.1200/JCO.19.02105",
              "PMC8184060",
              "31682550"
            ]
          },
          {
            "Citation": "Dong H., Strome S.E., Salomao D.R., Tamura H., Hirano F., Flies D.B., Roche P.C., Lu J., Zhu G., Tamada K., et al. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion. Nat. Med. 2002;8:793\u2013800. doi: 10.1038/nm730.",
            "ArticleIdList": [
              "10.1038/nm730",
              "12091876"
            ]
          },
          {
            "Citation": "Herbst R.S., Arkenau H.T., Santana-Davila R., Calvo E., Paz-Ares L., Cassier P.A., Bendell J., Penel N., Krebs M.G., Martin-Liberal J., et al. Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): A multicohort, non-randomised, open-label, phase 1a/b trial. Lancet Oncol. 2019;20:1109\u20131123. doi: 10.1016/S1470-2045(19)30458-9.",
            "ArticleIdList": [
              "10.1016/S1470-2045(19)30458-9",
              "31301962"
            ]
          },
          {
            "Citation": "Jafferji M.S., Yang J.C. Adoptive T-Cell Therapy for Solid Malignancies. Surg. Oncol. Clin. N. Am. 2019;28:465\u2013479. doi: 10.1016/j.soc.2019.02.012.",
            "ArticleIdList": [
              "10.1016/j.soc.2019.02.012",
              "31079800"
            ]
          },
          {
            "Citation": "Paulos C.M., Kaiser A., Wrzesinski C., Hinrichs C.S., Cassard Loni A., Muranski P., Sanchez-Perez L., Palmer D.C., Yu Z., Antony P.A. Toll-like receptors in tumor immunotherapy. Clin. Cancer Res. 2007;13:5280\u20135289. doi: 10.1158/1078-0432.CCR-07-1378.",
            "ArticleIdList": [
              "10.1158/1078-0432.CCR-07-1378",
              "PMC2131730",
              "17875756"
            ]
          },
          {
            "Citation": "Chudasama R., Phung Q., Hsu A., Almhanna K. Vaccines in Gastrointestinal Malignan-cies: From Prevention to Treatment. Vaccines. 2021;9:647. doi: 10.3390/vaccines9060647.",
            "ArticleIdList": [
              "10.3390/vaccines9060647",
              "PMC8231997",
              "34199248"
            ]
          },
          {
            "Citation": "Hollingsworth R.E., Jansen K. Turning the corner on therapeutic cancer vaccines. NPJ Vaccines. 2019;4:7. doi: 10.1038/s41541-019-0103-y.",
            "ArticleIdList": [
              "10.1038/s41541-019-0103-y",
              "PMC6368616",
              "30774998"
            ]
          },
          {
            "Citation": "Ogasawara M. Dendritic cell vaccine-based immunotherapy in combination with sal-vage chemotherapy for patients with advanced or relapsed gastric cancer. Ann. Oncol. 2018;29:v21. doi: 10.1093/annonc/mdy151.074.",
            "ArticleIdList": [
              "10.1093/annonc/mdy151.074"
            ]
          },
          {
            "Citation": "Ajani J.A., Hecht J.R., Ho L., Baker J., Oortgiesen M., Eduljee A., Michaeli D. An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: The GC4 study. Cancer. 2006;106:1908\u20131916. doi: 10.1002/cncr.21814.",
            "ArticleIdList": [
              "10.1002/cncr.21814",
              "16568451"
            ]
          },
          {
            "Citation": "Fujiwara Y., Sugimura K., Miyata H., Omori T., Nakano H., Mochizuki C., Shimizu K., Saito H. A pilot study of post-operative adjuvant vaccine for advanced gastric cancer Adjuvant cancer vaccine for gastric cancer. Yonago Acta Med. 2017;60:101\u2013105. doi: 10.33160/yam.2017.06.005.",
            "ArticleIdList": [
              "10.33160/yam.2017.06.005",
              "PMC5502221",
              "28701892"
            ]
          },
          {
            "Citation": "Guo Z., Zhang Y., Xu W., Zhang X., Jiang J. Engineered exosome-mediated delivery of circDIDO1 inhibits gastric cancer progression via regulation of MiR-1307-3p/SOCS2 Ax-is. J. Transl. Med. 2022;20:326. doi: 10.1186/s12967-022-03527-z.",
            "ArticleIdList": [
              "10.1186/s12967-022-03527-z",
              "PMC9306104",
              "35864511"
            ]
          },
          {
            "Citation": "Wu H., Fu M., Liu J., Chong W., Fang Z., Du F., Liu Y., Shang L., Li L. The role and application of small extracellular vesicles in gastric cancer. Mol. Cancer. 2021;20:71. doi: 10.1186/s12943-021-01365-z.",
            "ArticleIdList": [
              "10.1186/s12943-021-01365-z",
              "PMC8081769",
              "33926452"
            ]
          },
          {
            "Citation": "Johnson L.A., June C.H. Driving gene-engineered T cell immunotherapy of cancer. Cell Res. 2017;27:38\u201358. doi: 10.1038/cr.2016.154.",
            "ArticleIdList": [
              "10.1038/cr.2016.154",
              "PMC5223234",
              "28025979"
            ]
          },
          {
            "Citation": "Paulos C.M., Wrzesinski C., Kaiser A., Hinrichs C.S., Chieppa M., Cassard L., Palmer D.C., Boni A., Muranski P., Yu Z., et al. Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J. Clin. Investig. 2007;117:2197\u20132204. doi: 10.1172/JCI32205.",
            "ArticleIdList": [
              "10.1172/JCI32205",
              "PMC1924500",
              "17657310"
            ]
          },
          {
            "Citation": "Lida N., Dzutsev A., Stewart C.A., Smith L., Bouladoux N., Weingarten R.A., Molina D.A., Salcedo R., Back T., Cramer S., et al. Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science. 2013;342:967\u2013970. doi: 10.1126/science.1240527.",
            "ArticleIdList": [
              "10.1126/science.1240527",
              "PMC6709532",
              "24264989"
            ]
          },
          {
            "Citation": "Routy B., Le Chatelier E., Derosa L., Duong C.P.M., Alou M.T., Daill\u00e8re R., Fluckiger A., Messaoudene M., Rauber C., Roberti M.P. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 2018;359:91\u201397. doi: 10.1126/science.aan3706.",
            "ArticleIdList": [
              "10.1126/science.aan3706",
              "29097494"
            ]
          },
          {
            "Citation": "McGee M.D., Borstein S.R., Neches R.Y., Buescher H.H., Seehausen O., Wainwright P.C. A pharyngeal jaw evolutionary innovation facilitated extinction in Lake Victoria cichlids. Science. 2015;350:1077\u20131079. doi: 10.1126/science.aab0800.",
            "ArticleIdList": [
              "10.1126/science.aab0800",
              "26612951"
            ]
          },
          {
            "Citation": "Sivan A., Corrales L., Hubert N., Williams J.B., Aquino-Michaels K., Earley Z.M., Benyamin F.W., Lei Y.M., Jabri B., Alegre M.L. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015;350:1084\u20131089. doi: 10.1126/science.aac4255.",
            "ArticleIdList": [
              "10.1126/science.aac4255",
              "PMC4873287",
              "26541606"
            ]
          },
          {
            "Citation": "Gopalakrishnan V., Spencer C.N., Nezi L., Reuben A., Andrews M.C., Karpinets T.V., Prieto P.A., Vicente D., Hoffman K., Wei S.C., et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018;359:97\u2013103. doi: 10.1126/science.aan4236.",
            "ArticleIdList": [
              "10.1126/science.aan4236",
              "PMC5827966",
              "29097493"
            ]
          },
          {
            "Citation": "Baruch E.N., Youngster I., Ben-Betzalel G., Ortenberg R., Lahat A., Katz L., Adler K., Dick-Necula D., Raskin S., Bloch N., et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science. 2021;371:602\u2013609. doi: 10.1126/science.abb5920.",
            "ArticleIdList": [
              "10.1126/science.abb5920",
              "33303685"
            ]
          },
          {
            "Citation": "Lu Y., Yuan X., Wang M., He Z., Li H., Wang J., Li Q. Gut microbiota influence immunotherapy responses: Mechanisms and therapeutic strategies. J. Hematol. Oncol. 2022;15:47. doi: 10.1186/s13045-022-01273-9.",
            "ArticleIdList": [
              "10.1186/s13045-022-01273-9",
              "PMC9052532",
              "35488243"
            ]
          },
          {
            "Citation": "Inamura K. Gut microbiota contributes towards immunomodulation against cancer: New frontiers in precision cancer therapeutics. Semin. Cancer Biol. 2021;70:11\u201323. doi: 10.1016/j.semcancer.2020.06.006.",
            "ArticleIdList": [
              "10.1016/j.semcancer.2020.06.006",
              "32580023"
            ]
          },
          {
            "Citation": "Postow M.A., Sidlow R., Hellmann M.D. Immune-Related Adverse Events Associated with Immune Checkpoint Blockade. N. Engl. J. Med. 2018;378:158\u2013168. doi: 10.1056/NEJMra1703481.",
            "ArticleIdList": [
              "10.1056/NEJMra1703481",
              "29320654"
            ]
          },
          {
            "Citation": "Gori S., Inno A., Belluomini L., Bocus P., Bisoffi Z., Russo A., Arcaro G. Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy. Crit. Rev. Oncol. Hematol. 2019;143:139\u2013147. doi: 10.1016/j.critrevonc.2019.09.003.",
            "ArticleIdList": [
              "10.1016/j.critrevonc.2019.09.003",
              "31634731"
            ]
          },
          {
            "Citation": "Oster P., Vaillant L., Riva E., McMillan B., Begka C., Truntzer C., Richard C., Leblond M.M., Messaoudene M., Machremi E., et al. Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies. Gut. 2022;71:457\u2013466. doi: 10.1136/gutjnl-2020-323392.",
            "ArticleIdList": [
              "10.1136/gutjnl-2020-323392",
              "PMC8862014",
              "34253574"
            ]
          },
          {
            "Citation": "Che H., Xiong Q., Ma J., Chen S., Wu H., Xu H., Hou B. Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors. BMC Cancer. 2022;22:904. doi: 10.1186/s12885-022-10004-9.",
            "ArticleIdList": [
              "10.1186/s12885-022-10004-9",
              "PMC9389789",
              "35986342"
            ]
          },
          {
            "Citation": "Magahis P.T., Maron S.B., Cowzer D., King S., Schattner M., Janjigian Y., Faleck D., Laszkowska M. Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors. J. Immunother. Cancer. 2023;11:e007699. doi: 10.1136/jitc-2023-007699.",
            "ArticleIdList": [
              "10.1136/jitc-2023-007699",
              "PMC10619027",
              "37899129"
            ]
          },
          {
            "Citation": "Li N., Bai C., Zhao L., Sun Z., Ge Y., Li X. The Relationship Between Gut Microbiome Features and Chemotherapy Response in Gastrointestinal Cancer. Front. Oncol. 2021;11:781697. doi: 10.3389/fonc.2021.781697.",
            "ArticleIdList": [
              "10.3389/fonc.2021.781697",
              "PMC8733568",
              "35004303"
            ]
          },
          {
            "Citation": "Liu W., Ma F., Sun B., Liu Y., Tang H., Luo J., Chen H., Luo Z. Intestinal Microbiome Associated with Immune-Related Adverse Events for Patients Treated with Anti-PD-1 Inhibitors, a Real-World Study. Front. Immunol. 2021;12:756872. doi: 10.3389/fimmu.2021.756872.",
            "ArticleIdList": [
              "10.3389/fimmu.2021.756872",
              "PMC8716485",
              "34975845"
            ]
          },
          {
            "Citation": "Brown K., DeCoffe D., Molcan E., Gibson D.L. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients. 2012;4:1095\u20131119. doi: 10.3390/nu4081095.",
            "ArticleIdList": [
              "10.3390/nu4081095",
              "PMC3448089",
              "23016134"
            ]
          },
          {
            "Citation": "Adak A., Khan M.R. An insight into gut microbiota and its functionalities. Cell Mol. Life Sci. 2019;76:473\u2013493. doi: 10.1007/s00018-018-2943-4.",
            "ArticleIdList": [
              "10.1007/s00018-018-2943-4",
              "PMC11105460",
              "30317530"
            ]
          },
          {
            "Citation": "Singh R.K., Chang H.W., Yan D., Lee K.M., Ucmak D., Wong K., Abrouk M., Farahnik B., Nakamura M., Zhu T.H., et al. Influence of diet on the gut microbiome and implications for human health. J. Transl. Med. 2017;15:73. doi: 10.1186/s12967-017-1175-y.",
            "ArticleIdList": [
              "10.1186/s12967-017-1175-y",
              "PMC5385025",
              "28388917"
            ]
          },
          {
            "Citation": "Ghoshal S., Witta J., Zhong J., de Villiers W., Eckhardt E. Chylomicrons promote intestinal absorption of lipopolysaccharides. J. Lipid Res. 2009;50:90\u201397. doi: 10.1194/jlr.M800156-JLR200.",
            "ArticleIdList": [
              "10.1194/jlr.M800156-JLR200",
              "18815435"
            ]
          },
          {
            "Citation": "Akira S., Takeda K. Toll-like receptor signaling. Nat. Rev. Immunol. 2004;4:499\u2013511. doi: 10.1038/nri1391.",
            "ArticleIdList": [
              "10.1038/nri1391",
              "15229469"
            ]
          },
          {
            "Citation": "Ratajczak W., Ry\u0142 A., Mizerski A., Walczakiewicz K., Sipak O., Laszczy\u0144ska M. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs) Acta Biochim. Pol. 2019;66:1\u201312. doi: 10.18388/abp.2018_2648.",
            "ArticleIdList": [
              "10.18388/abp.2018_2648",
              "30831575"
            ]
          },
          {
            "Citation": "Kobayasi R., Akamine E.H., Davel A.P., Rodrigues M.A., Carvalho C.R., Rossoni L.V. Oxidative stress and inflammatory mediators contribute to endothelial dysfunction in high-fat diet-induced obesity in mice. J. Hypertens. 2010;28:2111\u20132119. doi: 10.1097/HJH.0b013e32833ca68c.",
            "ArticleIdList": [
              "10.1097/HJH.0b013e32833ca68c",
              "20616756"
            ]
          },
          {
            "Citation": "Slavin J. Fiber and prebiotics: Mechanisms and health benefits. Nutrients. 2013;5:1417\u20131435. doi: 10.3390/nu5041417.",
            "ArticleIdList": [
              "10.3390/nu5041417",
              "PMC3705355",
              "23609775"
            ]
          },
          {
            "Citation": "Niccolai E., Baldi S., Ricci F., Russo E., Nannini G., Menicatti M., Poli G., Taddei A., Bartolucci G., Calabr\u00f2 A.S. Evaluation and comparison of short-chain fatty acids composition in gut diseases. World J. Gastroenterol. 2019;25:5543\u20135558. doi: 10.3748/wjg.v25.i36.5543.",
            "ArticleIdList": [
              "10.3748/wjg.v25.i36.5543",
              "PMC6767983",
              "31576099"
            ]
          },
          {
            "Citation": "De Rosa V., Galgani M., Santopaolo M., Colamatteo A., Laccetti R., Matarese G. Nutritional control of immunity: Balancing the metabolic requirements with an appropriate immune function. Semin. Immunol. 2015;27:300\u2013309. doi: 10.1016/j.smim.2015.10.001.",
            "ArticleIdList": [
              "10.1016/j.smim.2015.10.001",
              "26527507"
            ]
          },
          {
            "Citation": "Costantini L., Molinari R., Farinon B., Merendino N. Impact of Omega-3 Fatty Acids on the Gut Microbiota. Int. J. Mol. Sci. 2017;18:2645. doi: 10.3390/ijms18122645.",
            "ArticleIdList": [
              "10.3390/ijms18122645",
              "PMC5751248",
              "29215589"
            ]
          },
          {
            "Citation": "Tosti V., Bertozzi B., Fontana L. Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms. J. Gerontol. A Biol. Sci. Med. Sci. 2018;73:318\u2013326. doi: 10.1093/gerona/glx227.",
            "ArticleIdList": [
              "10.1093/gerona/glx227",
              "PMC7190876",
              "29244059"
            ]
          },
          {
            "Citation": "Dunn G.P., Bruce A.T., Ikeda H., Old L.J., Schreiber R.D. Cancer immunoediting: From immunosurveillance to tumor escape. Nat. Immunol. 2002;3:991\u2013998. doi: 10.1038/ni1102-991.",
            "ArticleIdList": [
              "10.1038/ni1102-991",
              "12407406"
            ]
          },
          {
            "Citation": "Klement R.J., Pazienza V. Impact of Different Types of Diet on Gut Microbiota Profiles and Cancer Prevention and Treatment. Medicina. 2019;55:84. doi: 10.3390/medicina55040084.",
            "ArticleIdList": [
              "10.3390/medicina55040084",
              "PMC6524347",
              "30934960"
            ]
          },
          {
            "Citation": "Zitvogel L., Ma Y., Raoult D., Kroemer G., Gajewski T.F. The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies. Science. 2018;359:1366\u20131370. doi: 10.1126/science.aar6918.",
            "ArticleIdList": [
              "10.1126/science.aar6918",
              "29567708"
            ]
          },
          {
            "Citation": "Quail D.F., Dannenberg A.J. The obese adipose tissue microenvironment in cancer development and progression. Nat. Rev. Endocrinol. 2019;15:139\u2013154. doi: 10.1038/s41574-018-0126-x.",
            "ArticleIdList": [
              "10.1038/s41574-018-0126-x",
              "PMC6374176",
              "30459447"
            ]
          },
          {
            "Citation": "Turbitt W.J., Demark-Wahnefried W., Peterson C.M., Norian L.A. Targeting Glucose Metabolism to Enhance Immunotherapy: Emerging Evidence on Intermittent Fasting and Calorie Restriction Mimetics. Front. Immunol. 2019;10:1402. doi: 10.3389/fimmu.2019.01402.",
            "ArticleIdList": [
              "10.3389/fimmu.2019.01402",
              "PMC6603129",
              "31293576"
            ]
          },
          {
            "Citation": "Verhoog S., Taneri P.E., Roa D\u00edaz Z.M., Marques-Vidal P., Troup J.P., Bally L., Franco O.H., Glisic M., Muka T. Dietary Factors and Modulation of Bacteria Strains of Akkermansia muciniphila and Faecalibacterium prausnitzii: A Systematic Review. Nutrients. 2019;11:1565. doi: 10.3390/nu11071565.",
            "ArticleIdList": [
              "10.3390/nu11071565",
              "PMC6683038",
              "31336737"
            ]
          },
          {
            "Citation": "Benus R.F., van der Werf T.S., Welling G.W., Judd P.A., Taylor M.A., Harmsen H.J., Whelan K. Association between Faecalibacterium prausnitzii and dietary fibre in colonic fermentation in healthy human subjects. Br. J. Nutr. 2010;104:693\u2013700. doi: 10.1017/S0007114510001030.",
            "ArticleIdList": [
              "10.1017/S0007114510001030",
              "20346190"
            ]
          },
          {
            "Citation": "Bersanelli M., Leonetti A., Buti S. The link between calcitriol and anticancer immunotherapy: Vitamin D as the possible balance between inflammation and autoimmunity in the immune-checkpoint blockade. Immunotherapy. 2017;9:1127\u20131131. doi: 10.2217/imt-2017-0127.",
            "ArticleIdList": [
              "10.2217/imt-2017-0127",
              "29067883"
            ]
          },
          {
            "Citation": "Sheikh V., Kasapoglu P., Zamani A., Basiri Z., Tahamoli-Roudsari A., Alahgholi-Hajibehzad M. Vitamin D3 inhibits the proliferation of T helper cells, downregulate CD4+ T cell cytokines and upregulate inhibitory markers. Hum. Immunol. 2018;79:439\u2013445. doi: 10.1016/j.humimm.2018.03.001.",
            "ArticleIdList": [
              "10.1016/j.humimm.2018.03.001",
              "29522785"
            ]
          },
          {
            "Citation": "Meyer D., Stasse-Wolthuis M. The bifidogenic effect of inulin and oligofructose and its consequences for gut health. Eur. J. Clin. Nutr. 2009;63:1277\u20131289. doi: 10.1038/ejcn.2009.64.",
            "ArticleIdList": [
              "10.1038/ejcn.2009.64",
              "19690573"
            ]
          },
          {
            "Citation": "Vulevic J., Juric A., Tzortzis G., Gibson G.R. A mixture of trans-galactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J. Nutr. 2013;143:324\u2013331. doi: 10.3945/jn.112.166132.",
            "ArticleIdList": [
              "10.3945/jn.112.166132",
              "23303873"
            ]
          },
          {
            "Citation": "Mego M., Holec V., Drgona L., Hainova K., Ciernikova S., Zajac V. Probiotic bacteria in cancer patients undergoing chemotherapy and radiation therapy. Complement. Ther. Med. 2013;21:712\u2013723. doi: 10.1016/j.ctim.2013.08.018.",
            "ArticleIdList": [
              "10.1016/j.ctim.2013.08.018",
              "24280481"
            ]
          },
          {
            "Citation": "Indini A., Rijavec E., Ghidini M., Tomasello G., Cattaneo M., Barbin F., Bareggi C., Galassi B., Gambini D., Grossi F. Impact of BMI on Survival Outcomes of Immunotherapy in Solid Tumors: A Systematic Review. Int. J. Mol. Sci. 2021;22:2628. doi: 10.3390/ijms22052628.",
            "ArticleIdList": [
              "10.3390/ijms22052628",
              "PMC7961496",
              "33807855"
            ]
          },
          {
            "Citation": "An Y., Wu Z., Wang N., Yang Z., Li Y., Xu B., Sun M. Association between body mass index and survival outcomes for cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis. J. Transl. Med. 2020;18:235. doi: 10.1186/s12967-020-02404-x.",
            "ArticleIdList": [
              "10.1186/s12967-020-02404-x",
              "PMC7291531",
              "32532255"
            ]
          },
          {
            "Citation": "Rejeski K., Cordas Dos Santos D.M., Parker N.H., B\u00fccklein V.L., Winkelmann M., Jhaveri K.S., Liu L., Trinkner P., G\u00fcnther S., Karschnia P., et al. Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy. Cancer Immunol. Res. 2023;11:707\u2013719. doi: 10.1158/2326-6066.CIR-22-0487.",
            "ArticleIdList": [
              "10.1158/2326-6066.CIR-22-0487",
              "PMC10236147",
              "37040425"
            ]
          },
          {
            "Citation": "Lin G.T., Huang J.B., Lin J.L., Lin J.X., Xie J.W., Wang J.B., Lu J., Zheng C.H., Huang C.M., Li P. Body composition parameters for predicting the efficacy of neoadjuvant chemotherapy with immunotherapy for gastric cancer. Front. Immunol. 2022;13:1061044. doi: 10.3389/fimmu.2022.1061044.",
            "ArticleIdList": [
              "10.3389/fimmu.2022.1061044",
              "PMC9772614",
              "36569876"
            ]
          },
          {
            "Citation": "Kano M., Hihara J., Tokumoto N., Kohashi T., Hara T., Shimbara K., Takahashi S. Association between skeletal muscle loss and the response to nivolumab immunotherapy in advanced gastric cancer patients. Int. J. Clin. Oncol. 2021;26:523\u2013531. doi: 10.1007/s10147-020-01833-4.",
            "ArticleIdList": [
              "10.1007/s10147-020-01833-4",
              "33226523"
            ]
          },
          {
            "Citation": "Johannet P., Sawyers A., Qian Y., Kozloff S., Gulati N., Donnelly D., Zhong J., Osman I. Baseline prognostic nutritional index and changes in pretreatment body mass index associate with immunotherapy response in patients with advanced cancer. J. Immunother. Cancer. 2020;8:e001674. doi: 10.1136/jitc-2020-001674.",
            "ArticleIdList": [
              "10.1136/jitc-2020-001674",
              "PMC7682457",
              "33219093"
            ]
          },
          {
            "Citation": "Pan Y., Ma Y., Dai G. The Prognostic Value of the Prognostic Nutritional Index in Patients with Advanced or Metastatic Gastric Cancer Treated with Immunotherapy. Nutrients. 2023;15:4290. doi: 10.3390/nu15194290.",
            "ArticleIdList": [
              "10.3390/nu15194290",
              "PMC10574242",
              "37836573"
            ]
          },
          {
            "Citation": "Zhang Y., Jin J., Tang M., Li P., Zhou L.N., Du Y.P., Chen M.B. Prognostic Nutritional Index Predicts Outcome of PD-L1 Negative and MSS Advanced Cancer Treated with PD-1 Inhibitors. Biomed. Res. Int. 2022;2022:6743126. doi: 10.1155/2022/6743126.",
            "ArticleIdList": [
              "10.1155/2022/6743126",
              "PMC9192216",
              "35707390"
            ]
          },
          {
            "Citation": "Zhang J., Li M., Zhang L., Kuang T., Yu J., Wang W. Prognostic value of controlling nutritional status on clinical and survival outcomes in cancer patients treated with immunotherapy. Sci. Rep. 2023;13:17715. doi: 10.1038/s41598-023-45096-1.",
            "ArticleIdList": [
              "10.1038/s41598-023-45096-1",
              "PMC10584918",
              "37853186"
            ]
          },
          {
            "Citation": "Andoh A., Nishida A., Takahashi K., Inatomi O., Imaeda H., Bamba S., Kito K., Sugimoto M., Kobayashi T. Comparison of the gut microbial community between obese and lean peoples using 16S gene sequencing in a Japanese population. J. Clin. Biochem. Nutr. 2016;59:65\u201370. doi: 10.3164/jcbn.15-152.",
            "ArticleIdList": [
              "10.3164/jcbn.15-152",
              "PMC4933688",
              "27499582"
            ]
          },
          {
            "Citation": "Companys J., Gosalbes M.J., Pla-Pag\u00e0 L., Calder\u00f3n-P\u00e9rez L., Llaurad\u00f3 E., Pedret A., Valls R.M., Jim\u00e9nez-Hern\u00e1ndez N., Sandoval-Ramirez B.A., Del Bas J.M., et al. Gut Microbiota Profile and Its Association with Clinical Variables and Dietary Intake in Overweight/Obese and Lean Subjects: A Cross-Sectional Study. Nutrients. 2021;13:2032. doi: 10.3390/nu13062032.",
            "ArticleIdList": [
              "10.3390/nu13062032",
              "PMC8231825",
              "34199239"
            ]
          },
          {
            "Citation": "Allen J.M., Mailing L.J., Niemiro G.M., Moore R., Cook M.D., White B.A., Holscher H.D., Woods J.A. Exercise Alters Gut Microbiota Composition and Function in Lean and Obese Humans. Med. Sci. Sports Exerc. 2018;50:747\u2013757. doi: 10.1249/MSS.0000000000001495.",
            "ArticleIdList": [
              "10.1249/MSS.0000000000001495",
              "29166320"
            ]
          },
          {
            "Citation": "Gruneck L., Kullawong N., Kespechara K., Popluechai S. Gut microbiota of obese and diabetic Thai subjects and interplay with dietary habits and blood profiles. PeerJ. 2020;8:e9622. doi: 10.7717/peerj.9622.",
            "ArticleIdList": [
              "10.7717/peerj.9622",
              "PMC7409811",
              "32832269"
            ]
          },
          {
            "Citation": "Kasai C., Sugimoto K., Moritani I., Tanaka J., Oya Y., Inoue H., Tameda M., Shiraki K., Ito M., Takei Y., et al. Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing. BMC Gastroenterol. 2015;15:100. doi: 10.1186/s12876-015-0330-2.",
            "ArticleIdList": [
              "10.1186/s12876-015-0330-2",
              "PMC4531509",
              "26261039"
            ]
          },
          {
            "Citation": "Beaumont M., Goodrich J.K., Jackson M.A., Yet I., Davenport E.R., Vieira-Silva S., Debelius J., Pallister T., Mangino M., Raes J., et al. Heritable components of the human fecal microbiome are associated with visceral fat. Genome Biol. 2016;17:189. doi: 10.1186/s13059-016-1052-7.",
            "ArticleIdList": [
              "10.1186/s13059-016-1052-7",
              "PMC5036307",
              "27666579"
            ]
          },
          {
            "Citation": "Lahiri S., Kim H., Garcia-Perez I., Reza M.M., Martin K.A., Kundu P., Cox L.M., Selkrig J., Posma J.M., Zhang H., et al. The gut microbiota influences skeletal muscle mass and function in mice. Sci. Transl. Med. 2019;11:eaan5662. doi: 10.1126/scitranslmed.aan5662.",
            "ArticleIdList": [
              "10.1126/scitranslmed.aan5662",
              "PMC7501733",
              "31341063"
            ]
          },
          {
            "Citation": "Clarke S.F., Murphy E.F., O\u2019Sullivan O., Lucey A.J., Humphreys M., Hogan A., Hayes P., O\u2019Reilly M., Jeffery I.B., Wood-Martin R., et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut. 2014;63:1913\u20131920. doi: 10.1136/gutjnl-2013-306541.",
            "ArticleIdList": [
              "10.1136/gutjnl-2013-306541",
              "25021423"
            ]
          },
          {
            "Citation": "Lv W.Q., Lin X., Shen H., Liu H.M., Qiu X., Li B.Y., Shen W.D., Ge C.L., Lv F.Y., Shen J., et al. Human gut microbiome impacts skeletal muscle mass via gut microbial synthesis of the short-chain fatty acid butyrate among healthy menopausal women. J. Cachexia Sarcopenia Muscle. 2021;12:1860\u20131870. doi: 10.1002/jcsm.12788.",
            "ArticleIdList": [
              "10.1002/jcsm.12788",
              "PMC8718076",
              "34472211"
            ]
          },
          {
            "Citation": "Frug\u00e9 A.D., Van der Pol W., Rogers L.Q., Morrow C.D., Tsuruta Y., Demark-Wahnefried W. Fecal Akkermansia muciniphila Is Associated with Body Composition and Microbiota Diversity in Overweight and Obese Women with Breast Cancer Participating in a Presurgical Weight Loss Trial. J. Acad. Nutr. Diet. 2020;120:650\u2013659. doi: 10.1016/j.jand.2018.08.164.",
            "ArticleIdList": [
              "10.1016/j.jand.2018.08.164",
              "PMC6509025",
              "30420171"
            ]
          },
          {
            "Citation": "Bressa C., Bail\u00e9n-Andrino M., P\u00e9rez-Santiago J., Gonz\u00e1lez-Soltero R., P\u00e9rez M., Montalvo-Lominchar M.G., Mat\u00e9-Mu\u00f1oz J.L., Dom\u00ednguez R., Moreno D., Larrosa M., et al. Differences in gut microbiota profile between women with active lifestyle and sedentary women. PLoS ONE. 2017;12:e0171352. doi: 10.1371/journal.pone.0171352.",
            "ArticleIdList": [
              "10.1371/journal.pone.0171352",
              "PMC5302835",
              "28187199"
            ]
          },
          {
            "Citation": "Picca A., Ponziani F.R., Calvani R., Marini F., Biancolillo A., Coelho-Junior H.J., Gervasoni J., Primiano A., Putignani L., Del Chierico F., et al. Gut Microbial, Inflammatory and Metabolic Signatures in Older People with Physical Frailty and Sarcopenia: Results from the BIOSPHERE Study. Nutrients. 2019;12:65. doi: 10.3390/nu12010065.",
            "ArticleIdList": [
              "10.3390/nu12010065",
              "PMC7019826",
              "31887978"
            ]
          },
          {
            "Citation": "Ticinesi A., Mancabelli L., Tagliaferri S., Nouvenne A., Milani C., Del Rio D., Lauretani F., Maggio M.G., Ventura M., Meschi T. The Gut-Muscle Axis in Older Subjects with Low Muscle Mass and Performance: A Proof of Concept Study Exploring Fecal Microbiota Composition and Function with Shotgun Metagenomics Sequencing. Int. J. Mol. Sci. 2020;21:8946. doi: 10.3390/ijms21238946.",
            "ArticleIdList": [
              "10.3390/ijms21238946",
              "PMC7728056",
              "33255677"
            ]
          },
          {
            "Citation": "Dao M.C., Everard A., Aron-Wisnewsky J., Sokolovska N., Prifti E., Verger E.O., Kayser B.D., Levenez F., Chilloux J., Hoyles L., et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: Relationship with gut microbiome richness and ecology. Gut. 2016;65:426\u2013436. doi: 10.1136/gutjnl-2014-308778.",
            "ArticleIdList": [
              "10.1136/gutjnl-2014-308778",
              "26100928"
            ]
          },
          {
            "Citation": "Schneeberger M., Everard A., G\u00f3mez-Valad\u00e9s A.G., Matamoros S., Ram\u00edrez S., Delzenne N.M., Gomis R., Claret M., Cani P.D. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci. Rep. 2015;5:16643. doi: 10.1038/srep16643.",
            "ArticleIdList": [
              "10.1038/srep16643",
              "PMC4643218",
              "26563823"
            ]
          },
          {
            "Citation": "Rinninella E., Fagotti A., Cintoni M., Raoul P., Scaletta G., Quagliozzi L., Miggiano G.A.D., Sambia G., Gasbarrini A., Mele M.C. Nutritional Interventions to Improve Clinical Outcomes in Ovarian Cancer: A Systematic Review of Randomized Controlled Trials. Nutrients. 2019;11:1404. doi: 10.3390/nu11061404.",
            "ArticleIdList": [
              "10.3390/nu11061404",
              "PMC6627677",
              "31234395"
            ]
          }
        ],
        "ReferenceList": []
      }
    ],
    "History": [
      {
        "Year": "2024",
        "Month": "3",
        "Day": "15"
      },
      {
        "Year": "2024",
        "Month": "4",
        "Day": "14"
      },
      {
        "Year": "2024",
        "Month": "4",
        "Day": "23"
      },
      {
        "Year": "2024",
        "Month": "5",
        "Day": "24",
        "Hour": "12",
        "Minute": "46"
      },
      {
        "Year": "2024",
        "Month": "5",
        "Day": "24",
        "Hour": "12",
        "Minute": "45"
      },
      {
        "Year": "2024",
        "Month": "5",
        "Day": "24",
        "Hour": "9",
        "Minute": "35"
      },
      {
        "Year": "2024",
        "Month": "4",
        "Day": "26"
      }
    ],
    "PublicationStatus": "epublish",
    "ArticleIdList": [
      "38787209",
      "PMC11124250",
      "10.3390/pathogens13050357",
      "pathogens13050357"
    ]
  }
}